GINS4 may positively modulate the cell cycle process of HCC and potentially trigger the tumorigenesis and progression of HCC in a PI3K/AKT/mTOR dependent manner, which needs to be further experimental verification. This evidence concerns the gene PIK3CB and hepatocellular carcinoma.